Epidemiology of Klebsiella Pneumoniae in China

Klebsiella Pneumoniae Infection Clinical Trial

Official title:

Klebsiella Pneumoniae Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03598543
• Other study ID #: SRRSH-China-KP
• Status: Recruiting
• Start date: June 1, 2018
• Est. completion date: December 31, 2018

Study information

• Verified date: July 2018
• Source: Sir Run Run Shaw Hospital
• Contact: Ying-zhi FANG, Master
• Phone: +86 57186006811
• Email: fyz4817[@]126.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Klebsiella pneumoniae is one of the most common pathogens causing both community-onset and nosocomial infection. More worse, the emergency of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) had cause the clinical therapy be very difficult. However, there is not much empirical data as to the prevalence, risk factors, characteristics,outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.Thus, the study was aimed to investigate the epidemiology and risk factors, characteristics, outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.

Description:

All the patients with culture positive of Klebsiella pneumoniae were screened and reported to the the clinical doctors and confirmed by them. And the clinical characteristics of the patiens, such as baseline data, outcomes etc, were recorded. Finially, to find the prevalence, risk factors, characteristics, outcome and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: December 31, 2018
• Est. primary completion date: October 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• new confirmed community-onset or noscomial infection of Klebsiella pneumoniae infection

Exclusion Criteria:

• Age<18, or >85 years old; Mixed infection of Klebsiella pneumoniae and other microbes

Related Conditions & MeSH terms

• Infection
• Klebsiella Infections
• Klebsiella Pneumoniae Infection
• Pneumonia

Intervention

Other:
• no intervention
no intervention, this is an obervational study.

Locations

Country	Name	City	State
China	Sir Run Run Shaw Hospital	Hangzhou	Zhejiang

Sponsors (1)

Lead Sponsor	Collaborator
Sir Run Run Shaw Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	CRKP infection	Culture postitive results confirmed the infection of CRKP	6 months